New: Introducing the Finviz Futures Map

Daré Bioscience, Inc.

Contributing Author

Recent Articles by Daré Bioscience, Inc.

Aug-14	Dare Bioscience Reports Second Quarter 2025 Financial Results and Provides Corporate Update DARE GlobeNewswire
Aug-07	Dare Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025 DARE GlobeNewswire
Jul-29	Dare Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY Sildenafil Cream DARE GlobeNewswire
Jul-21	UPDATE - Dare Bioscience to Host August 6 Webinar: The DARE to PLAY Difference - The Sildenafil Cream That Raises the Bar DARE GlobeNewswire
Jul-21	Dare Bioscience to Host August 6 Webinar: The DARE to PLAY Difference - The Sildenafil Cream That Raises the Bar DARE GlobeNewswire
Jul-14	Positive Interim Phase 3 Results Highlight Potential of Ovaprene, Novel Hormone-Free Contraceptive DARE GlobeNewswire
Jul-11	Dare Bioscience Receives $6 Million Non-Dilutive Grant Installment; $37.8M to Date of up to $49M Commitment Supporting Smart Drug Delivery Device for Contraception; Platform has Broader Application Potential in Obesity and Metabolic Disorders DARE GlobeNewswire
Jun-12	Dare Bioscience Announces Adjournment of Annual Meeting of Stockholders DARE GlobeNewswire
Jun-04	Dare Bioscience and Rosy Wellness Announce Strategic Collaboration to Educate and Market Dare's DARE to PLAY Sildenafil Cream DARE GlobeNewswire
May-13	Dare Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update DARE GlobeNewswire
May-06	Dare Bioscience to Host First Quarter 2025 Financial Results and Company Update Conference Call and Webcast on May 13, 2025 DARE GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.